Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

The patient had paraneoplastic pemphigus without mucosal involvement.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Autoimmune skin diseases result from genetic and environmental factors disrupting immune checkpoints.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Major histocompatibility antigens are found in specific skin cells and structures, but not in sweat glands.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Immunological skin diseases in pigs are rare and can be caused by immune system issues or external factors.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Atopy and altered T cell functions contribute to Alopecia Areata.

Biological therapy boosts the immune system to effectively fight melanoma.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Hair changes may indicate disease activity in pemphigus patients.

Immune cells are essential for early hair and skin development and healing.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.